`

POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

Biotechnology

Specialities :
Radioligand
Radiopharmaceutical
Cancer
And oncology
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$125.0M
size-icon Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company

What does Point biopharma, a wholly owned subsidiary of eli lilly and company do?+

POINT Biopharma develops next-generation radioligand therapies for the treatment of cancer

What are Point biopharma, a wholly owned subsidiary of eli lilly and company's specialties? +

Radioligand,radiopharmaceutical,cancer,and oncology

What is Point biopharma, a wholly owned subsidiary of eli lilly and company's industry? +

Point biopharma, a wholly owned subsidiary of eli lilly and company operates in the Biotechnology industry.

What is Point biopharma, a wholly owned subsidiary of eli lilly and company's revenue? +

Point biopharma, a wholly owned subsidiary of eli lilly and company's revenue is 11m - 100m

What is Point biopharma, a wholly owned subsidiary of eli lilly and company's company size? +

Point biopharma, a wholly owned subsidiary of eli lilly and company has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free